For almost six years, everything that has happened at private equity-owned Healthscope was supposed to be good for shareholders and the country.
Everything from paying $5.7 billion (including debt) to “strengthen, grow” the No.2 private hospitals group in June 2019 and funding it with property sales and debt, to throwing lenders the keys a fortnight ago was sunshine, rainbows and Brookfield doing the right thing.